GPP
ZYME icon

Great Point Partners’s Zymeworks ZYME Stock Holding History

Great Point Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-799,722
Closed -$37.8M – 39
2020
Q4 		$37.8M Sell
799,722
-768,178
-49% -$35.7M 6.14% 6
2020
Q3 		$73M Sell
1,567,900
-1,006,788
-39% -$34.6M 6.57% 5
2020
Q2 		$92.9M Buy
2,574,688
+250,000
+11% +$9.21M 7.42% 3
2020
Q1 		$82.5M Buy
2,324,688
+100,899
+5% +$4.13M 8.62% 2
2019
Q4 		$101M Sell
2,223,789
-242,955
-10% -$8.83M 8.8% 2
2019
Q3 		$61.2M Buy
2,466,744
+1,402,703
+132% +$35.1M 5.62% 6
2019
Q2 		$23.4M Buy
1,064,041
+1,049,431
+7,183% +$19.3M 2.6% 12
2019
Q1 		$236K Buy
+14,610
New +$227K 0.02% 39
2018
Q4 		– Sell
-241,970
Closed -$3.8M – 42
2018
Q3 		$3.8M Buy
+241,970
New +$3.46M 0.59% 25

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Great Point Partners's ZYME Position: Q1 2021 in Review

Great Point Partners sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 799,722 shares — an estimated $37.8M sold.

Great Point Partners first reported a position in ZYME in Q3 2018 and held it in 9 quarters. The position peaked at $101M in Q4 2019. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Great Point Partners reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Great Point Partners sold 799,722 Zymeworks shares in Q1 2021, an estimated $37.8M.
  • Great Point Partners first reported a position in Zymeworks in Q3 2018 and held it in 9 quarters.
  • Great Point Partners's Zymeworks position peaked at $101M in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Great Point Partners's 13F filing for Q1 2021, filed 17 May 2021.